Verve Therapeutics Stock Forecast
As of 2021 december 02, thursday current price of verv stock is 34.080$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). This price target is based on 5 analysts offering 12 month price targets for verve therapeutics in the last 3 months.
Earnings for verve therapeutics are expected to decrease in the coming year, from $0.09 to ($2.50) per share.
Verve therapeutics stock forecast. During the day the stock fluctuated 13.88% from a day low at $40.98 to a day high of $46.67. Et by tomi kilgore verve started at neutral with $50 stock price target at j.p. Analyst price target on verv.
The average price target is $71.20, with a high forecast of $92.00 and a low forecast of $50.00. And has now fallen 8 days in a row. On average, they anticipate verve therapeutics' stock price to reach $71.20 in the next year.
1 day) and price target of 47.42 usd. You'll find the verve therapeutics share forecasts, stock quote and buy / sell signals below.according to present data verve therapeutics's verv shares and potentially its market environment have been in a. About the verve therapeutics inc stock forecast.
A rank of 38 means that 62% of stocks appear more favorable. Investorsobserver gives verve therapeutics inc (verv) an overall rank of 38, which is below average. Verve therapeutics inc stock price forecast, verv predictons for2021
As stock downgraded to sell candidate. Verve's market cap is now almost $750m. Their forecasts range from $50.00 to $92.00.
Prasad now anticipates that the company will post earnings of $0.84 per share for the year, down from their previous forecast of. 24, 2021 at 8:00 a.m. View verve therapeutics verv investment & stock information.
Verv) is up 16.5% for the week. Analyst recommendations on verve therapeutics, inc. Weaker technical forecast for verve therapeutics, inc.
(nasdaq:verv) stock analysts at william blair lowered their fy2021 earnings estimates for shares of verve therapeutics in a report issued on wednesday, november 10th. Verve therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is wednesday, february 9th, 2022 based off prior year's report dates. The average price target represents a 66.67% upside from the last price of $42.72.
(verv) has a beta value of 0, and an average true range (atr) of 4.62. Verve therapeutics inc () stock market info recommendations: On average, wall street analysts predict that.
This chart shows the closing price for verv for. Wall street stock market & finance report, prediction for the future: The average price target is $68.67 with a high forecast of $84.00 and a low forecast of $50.00.
Stifel starts verve therapeutics at hold. Verve therapeutics inc stock price forecast for further price development up to 6.55% (time horizon: 2, 2021 when the stock price was at 32.94$.
Insiders who bought verve therapeutics, inc. And has now fallen 11 days in a row. The preferred stock tranche liability was settled as of.
The average verve therapeutics stock price prediction forecasts a potential downside of n/a from the current verv share price of $41.28. The gross proceeds to verve from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to. This suggests a possible upside of 72.4% from the stock's current price.
Verv stock forecast our latest prediction for verve therapeutics inc's stock price was made on the dec. Verve therapeutics started at hold with $58 stock price target at stifel nicolaus sep. Verve therapeutics stock price as been showing a rising tendency so we believe that similar market segments were very popular.
(nasdaq:verv) in the last 12 months may probably not pay attention to the stock's recent. Verve therapeutics inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. In the medium term (3months), verv's stock price.
The biotech stock, which was as low as $41.52 a share on monday, climbed as high as. We recorded a full valuation allowance on federal and state deferred tax assets since management does not forecast that we will be in a taxable position in the. Buy or sell verve therapeutics stock?
Verve therapeutics's share price could stay at $66.67 by sep 24, 2022. During the day the stock fluctuated 4.56% from a day low at $47.35 to a day high of $49.51. Based on 4 wall street analysts offering 12 month price targets for verve therapeutics in the last 3 months.
Find the latest verve therapeutics, inc.
Post a Comment for "Verve Therapeutics Stock Forecast"